Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | CoA or acetyl-CoA has no demonstrable effect on the HMP-P synthase ThiC in vitro | Salmonella enterica subsp. enterica |
Protein Variants | Comment | Organism |
---|---|---|
additional information | construction of strains DM13651 (zxx-8029::Tn10d(Tc) thiC1128 panE::Cm) and DM13652 (zxx-8029::Tn10d(Tc) thiC1129 panE::Cm), phenotypic analysis. Growth of representative suppressor strain DM13897 (thiC1129 panE::Cm ilvY3213) compared to parental strain DM13652 (thiC1129 panE::Cm) in minimal glucose medium: the parental thiC panE strain fails to grow on minimal glucose medium, but a suppressor derivative (DM13897) grows well. Growth of the parental strain is restored by the addition of thiamine (100 nM) or pantothenate | Salmonella enterica subsp. enterica |
ThiCE218K | site-directed mutagenesis, compromised ThiC variant weakly constrains the HMP pathway and the constraint is additive such that the combination of ThiCE218K or ThiCV267M with a lesion in panE prevents growth on minimal glucose medium | Salmonella enterica subsp. enterica |
ThiCV267M | site-directed mutagenesis, compromised ThiC variant weakly constrains the HMP pathway and the constraint is additive such that the combination of ThiCE218K or ThiCV267M with a lesion in panE prevents growth on minimal glucose medium | Salmonella enterica subsp. enterica |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | CoA or acetyl-CoA has no demonstrable effect on the HMP-P synthase ThiC in vitro | Salmonella enterica subsp. enterica |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
5-amino-1-(5-phospho-D-ribosyl)imidazole + S-adenosyl-L-methionine | Salmonella enterica subsp. enterica | - |
4-amino-2-methyl-5-(phosphooxymethyl)pyrimidine + 5'-deoxyadenosine + L-methionine + formate + CO | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Salmonella enterica subsp. enterica | Q9L9I7 | serovar typhimurium LT2 | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
5-amino-1-(5-phospho-D-ribosyl)imidazole + S-adenosyl-L-methionine | - |
Salmonella enterica subsp. enterica | 4-amino-2-methyl-5-(phosphooxymethyl)pyrimidine + 5'-deoxyadenosine + L-methionine + formate + CO | - |
? |
Synonyms | Comment | Organism |
---|---|---|
HMP-P synthase | - |
Salmonella enterica subsp. enterica |
thiC | - |
Salmonella enterica subsp. enterica |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
S-adenosyl-L-methionine | - |
Salmonella enterica subsp. enterica |
General Information | Comment | Organism |
---|---|---|
metabolism | ThiC catalyzes formation of HMP-P from the branch-point metabolite aminoimidazole ribotide (AIR), which is subsequently phosphorylated prior to being condensed with THZ-P to form thiamine-phosphate. Perturbation of the metabolic network in Salmonella enterica reveals cross-talk between coenzyme A and thiamine pathways connecting CoA and ThiC activity in vivo, pathways overview | Salmonella enterica subsp. enterica |
physiological function | thiamine pyrophosphate is an essential cofactor, and is made of two independently synthesized moieties, 4-methyl-5-(2-hydroxyethyl)-thiazole phosphate (THZ-P) and 4-amino-5-(hydroxymethyl)-2-methylpyrimidine phosphate (HMP-P), the latter is synthesized involving enzyme ThiC | Salmonella enterica subsp. enterica |